Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a single-centre prospective randomised study comparing the virological and
histological response of HBV infection to lamivudine in combination with interferon versus
lamivudine alone.